Latest News about GILD
Recent news which mentions GILD
Post-Pandemic Potential: Analysts Eye InflaRx COVID-19 Antibody For Market Breakthrough
April 06, 2023
From Benzinga
Texas Judge Obstructs Affordable Act Coverage Mandate For Some Cancer Screenings, Prophylaxis
March 31, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Is It Time to Buy These Ultra-Cheap Dividend Stocks?
March 29, 2023
From Motley Fool
Why Are Cathie Wood's Ark ETFs Still Trailing Nasdaq Stocks?
March 29, 2023
From Benzinga
From Motley Fool
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
March 27, 2023
From Benzinga
From Benzinga
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
From InvestorPlace
From Motley Fool
Gilead's Flagship CAR T-cell Therapy Shows Improved Overall Survival In Pretreated Lymphoma Patients
March 21, 2023
Tickers
GILD
From Benzinga
From Benzinga
From Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
From Benzinga
From InvestorPlace
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
March 15, 2023
From Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks Delivering High-Dividend Yields
March 10, 2023
From Benzinga
Why Shares of MacroGenics Jumped Thursday
March 09, 2023
From Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life
March 07, 2023
From Motley Fool
From Benzinga
7 Cash-Rich Companies to Invest in During Economic Uncertainty
February 26, 2023
From InvestorPlace
3 Stocks to Buy Right Now That Are Cash Cows
February 25, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.